"Tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.
| Descriptor ID |
D014376
|
| MeSH Number(s) |
C01.252.410.040.552.846
|
| Concept/Terms |
Tuberculosis- Tuberculosis
- Tuberculoses
- Koch's Disease
- Koch Disease
- Kochs Disease
- Mycobacterium tuberculosis Infection
- Infection, Mycobacterium tuberculosis
- Infections, Mycobacterium tuberculosis
- Mycobacterium tuberculosis Infections
|
Below are MeSH descriptors whose meaning is more general than "Tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Tuberculosis".
- Tuberculosis
- Latent Tuberculosis
- Peritonitis, Tuberculous
- Tuberculoma
- Tuberculosis, Avian
- Tuberculosis, Bovine
- Tuberculosis, Cardiovascular
- Tuberculosis, Central Nervous System
- Tuberculosis, Cutaneous
- Tuberculosis, Endocrine
- Tuberculosis, Gastrointestinal
- Tuberculosis, Hepatic
- Tuberculosis, Laryngeal
- Tuberculosis, Lymph Node
- Tuberculosis, Miliary
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Ocular
- Tuberculosis, Oral
- Tuberculosis, Osteoarticular
- Tuberculosis, Pleural
- Tuberculosis, Pulmonary
- Tuberculosis, Splenic
- Tuberculosis, Urogenital
This graph shows the total number of publications written about "Tuberculosis" by people in this website by year, and whether "Tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 0 | 4 |
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 5 | 1 | 6 |
| 2000 | 5 | 0 | 5 |
| 2001 | 5 | 0 | 5 |
| 2002 | 8 | 3 | 11 |
| 2003 | 3 | 0 | 3 |
| 2004 | 3 | 0 | 3 |
| 2005 | 4 | 3 | 7 |
| 2006 | 3 | 1 | 4 |
| 2007 | 8 | 1 | 9 |
| 2008 | 7 | 2 | 9 |
| 2009 | 2 | 0 | 2 |
| 2010 | 8 | 1 | 9 |
| 2011 | 15 | 0 | 15 |
| 2012 | 8 | 0 | 8 |
| 2013 | 14 | 0 | 14 |
| 2014 | 14 | 1 | 15 |
| 2015 | 8 | 1 | 9 |
| 2016 | 20 | 0 | 20 |
| 2017 | 18 | 2 | 20 |
| 2018 | 18 | 1 | 19 |
| 2019 | 28 | 1 | 29 |
| 2020 | 14 | 1 | 15 |
| 2021 | 12 | 2 | 14 |
| 2022 | 20 | 0 | 20 |
| 2023 | 17 | 0 | 17 |
| 2024 | 11 | 1 | 12 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tuberculosis" by people in Profiles.
-
Tuberculosis in adult migrants in Europe: a TBnet consensus statement. Eur Respir J. 2025 Mar; 65(3).
-
Safety of 3-month rifampicin-isoniazid TPT in child household contacts in a community-based intervention. Int J Tuberc Lung Dis. 2025 Feb 01; 29(2):67-74.
-
Effectiveness of the primary Bacillus Calmette-Gu?rin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data. Lancet Microbe. 2025 Feb; 6(2):100961.
-
TCA metabolism regulates DNA hypermethylation in LPS and Mycobacterium tuberculosis-induced immune tolerance. Proc Natl Acad Sci U S A. 2024 Oct 08; 121(41):e2404841121.
-
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers. AIDS Res Ther. 2024 Aug 29; 21(1):59.
-
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis. Lancet Glob Health. 2024 Aug; 12(8):e1225-e1226.
-
Candidate anti-tuberculosis medicines and regimens under clinical evaluation. Clin Microbiol Infect. 2024 Sep; 30(9):1131-1138.
-
Target regimen profiles for tuberculosis treatment. Bull World Health Organ. 2024 Aug 01; 102(8):600-607.
-
Parallel use of low-complexity automated nucleic acid amplification tests and lateral flow urine lipoarabinomannan assays to detect tuberculosis disease in adults and adolescents living with HIV. Cochrane Database Syst Rev. 2024 05 13; 5:CD016070.
-
Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles. Lancet Microbe. 2024 Sep; 5(9):100869.